These data suggest that induction of senescence through ribociclib is accompanied by a decreased responsiveness to various compounds, analogous to our previous observations on glucocorticoid receptor-mediated growth arrest induction in lung cancer [30]. The gene discussed is NR3C1; the disease is lung cancer.